Romania’s HPV vaccination efforts address cervical cancer, detailing current programs and public health challenges.
🔗 Read the article on hotnews.ro
[This is an automatically generated summary, for reference only]
In Romania, despite previous vaccination campaigns for HPV among young girls showing low uptake, a new campaign targets 2.8 million women. The HPV vaccine is effective against cervical cancer and other cancers, with nearly 3,500 Romanian women diagnosed annually with cervical cancer, placing the country high in European incidence and mortality rates. Doctors emphasize that HPV is a common sexually transmitted viral infection, but persistent infections can lead to pre-cancerous and cancerous lesions. Currently, Romania offers free HPV vaccination for girls aged 11-18 and boys aged 11-18 (since December 2023), with partial compensation offered to women aged 19-45 since the same date. Vaccination is most effective before sexual activity but remains beneficial afterward. The vaccine should be paired with an efficient screening program, as the progression from HPV infection to invasive cancer can take 10-15 years. While public trust in vaccines has seen a slight decline globally and in Romania, experts stress the importance of awareness campaigns.
